Sector: Pharmaceuticals & Biotechnology
|Small Cap
Lasa Supergenerics Ltd.
₹8.07
₹7.73
₹8.38
₹5.67
₹19.00
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 2.20 | 3.06 | 20.01 | 39.14 | 33.08 |
| Operating Expense | 2.95 | 7.06 | 20.51 | 35.72 | 32.29 |
| Operating Profit | -0.75 | -4 | -0.50 | 3.41 | 0.79 |
| Depreciation | 1.57 | 1.57 | 1.57 | 3.90 | 2.80 |
| Interest | 0.11 | 0.12 | 0.03 | 0.11 | 0.47 |
| Tax | 0.14 | 0.57 | -1.42 | -7.83 | 0.42 |
| Net Profit | -2.55 | -6.25 | -21.12 | -14.29 | 5.49 |
₹8.07
↗ Bullish Moving Average
10
↘ Bearish Moving Average
6
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 53.6 | 53.6 | 53.6 | 53.6 | 53.6 | 53.6 |
| FII | 0 | 0 | 0.5 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 46.4 | 46.4 | 45.9 | 46.4 | 46.3 | 46.4 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 10.61 K | 14.47 K | 73.31% |
| Week | 13.64 K | 16.04 K | 85.01% |
| 1 Month | 20.42 K | 21 K | 97.27% |
| 6 Month | 43.66 K | 59.94 K | 72.84% |
Companies with no Debt
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Results Screener: Stocks with upcoming results which are seeing positive shifts in share price
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Increasing profits every quarter for the past 2 quarters
Annual Net Profits improving for last 2 years
Stock with Low PE (PE < = 10)
High Volume, High Gain
Top Gainers
Volume Shockers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 16 Sep, 2022 | 0.25 | FINAL | Equity Share | |
| 15 Sep, 2021 | 0.25 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹492.90 | ₹6.40 | ₹131.01 | ₹13.79 | ₹559.75 | ₹852.80 |
| % Change | 1.27% | -2.14% | 0.71% | -0.86% | 0.46% | 0.53% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | ₹287.68 | - | ₹502.55 | ₹1,630.02 |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | ₹14.88 | - | ₹57.92 | ₹140.92 |
| PE TTM | - | -1.50 | 34.50 | - | 28.10 | 34.70 |
| 1 Year Return | 24.95 | 544 | 4.98 | 51.43 | -21.64 | -3.98 |
| ROCE | 3.56 | -5.63 | - | - | 23.87 | 15.27 |
Valiant Laboratories Ltd.
₹ 78.00
+1.46%
Sigachi Industries Ltd.
₹ 20.34
-0.05%
Windlas Biotech Ltd.
₹ 784.40
-0.70%
Vineet Laboratories Ltd.
₹ 35.00
-1.69%
Solara Active Pharma Sciences Ltd.
₹ 556.00
+1.44%
Zim Laboratories Ltd.
₹ 99.45
-0.71%
Medico Remedies Ltd.
₹ 48.93
+2.28%
Dishman Carbogen Amcis Ltd.
₹ 198.45
+1.58%
Advanced Enzyme Technologies Ltd.
₹ 376.50
+0.36%
Bajaj Healthcare Ltd.
₹ 302.20
-1.10%
Ortin Global Ltd.
₹ 15.06
-
Brooks Laboratories Ltd.
₹ 56.41
+4.99%
RPG Life Sciences Ltd.
₹ 2243.00
-2.22%
Bafna Pharmaceuticals Ltd.
₹ 135.50
+0.35%
Alpa Laboratories Ltd.
₹ 67.85
-1.89%
SMS Pharmaceuticals Ltd.
₹ 371.45
-2.62%
Nectar Lifesciences Ltd.
₹ 12.03
-0.25%
Mangalam Drugs and Organics Ltd.
₹ 29.01
-1.36%
Indoco Remedies Ltd.
₹ 195.70
-1.70%
Ind-Swift Laboratories Ltd.
₹ 133.00
+0.92%
Lincoln Pharmaceuticals Ltd.
₹ 722.00
-1.65%
Panacea Biotec Ltd.
₹ 419.90
+0.32%
Medicamen Biotech Ltd.
₹ 268.35
-0.45%
By signing up I certify terms, conditions & privacy policy